Cargando…

Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408

Background: As docetaxel plus S-1 may be feasible for cancer treatment, we conducted a phase I/II trial to determine the recommended docetaxel dose and the fixed S-1 dose (phase I), as well as confirm the regimen’s efficacy and safety (phase II) for previously-treated patients with advanced non-smal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takayama, Koichi, Uchino, Junji, Fujita, Masaki, Tokunaga, Shoji, Imanaga, Tomotoshi, Morinaga, Ryotaro, Ebi, Noriyuki, Saeki, Sho, Matsukizono, Kazuya, Wataya, Hiroshi, Yamada, Tadaaki, Nakanishi, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947543/ https://www.ncbi.nlm.nih.gov/pubmed/31842381 http://dx.doi.org/10.3390/jcm8122196

Ejemplares similares

Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801
por: Takayama, Koichi, et al.
Publicado: (2020)

Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)
por: Fukuda, Minoru, et al.
Publicado: (2016)

Digitale Logik
por: Stuckenberg, Hans Joachim
Publicado: (1970)

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)
por: Fukuda, Minoru, et al.
Publicado: (2016)

A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study
por: Tsuchiya, Tomoshi, et al.
Publicado: (2020)

Wissenschaft der Logik
por: Hegel, Georg Wilhelm Friedrich, 1770-1831
Publicado: (1948)

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer
por: Takayama, Koichi, et al.
Publicado: (2019)

Grundzüge der theoretischen Logik
por: Hilbert, David, et al.
Publicado: (1959)

Treatment rationale and design of the RAMNITA study: A phase II study of the efficacy of docetaxel + ramucirumab for non–small cell lung cancer with brain metastasis
por: Tanimura, Keiko, et al.
Publicado: (2018)

Zur Logik von Legitimationsproblemen : Möglichkeiten der Begründung von Normen /
por: Zedler, Hans-Peter, 1945-
Publicado: (1976)

Einführung in die Logik der Normen, Werte und Entscheidungen /
por: Kutschera, Franz von, 1932-
Publicado: (1973)

A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential
por: Liu, Xiaolei, et al.
Publicado: (2022)

Digitale Elektronik: die Arbeitsweise von integrierten Logik- und Speicher-Elementen
por: Wolf, Gerhard
Publicado: (1977)

HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
por: Hoffmann, Steve, et al.
Publicado: (2008)

Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer
por: Takayama, Koichi, et al.
Publicado: (2016)

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)
por: Wakuda, Kazushige, et al.
Publicado: (2020)

Grundzüge der Ontologie Sartres in ihrem Verhältnis zu Hegels Logik : eine Untersuchung zu L'être et le néant
por: Hartmann, Klaus 1925-1991‏
Publicado: (1963)

A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study
por: Tsuchiya, Tomoshi, et al.
Publicado: (2021)

Von der Schaltalgebra zum Mikroprozessor: die Mikroprozessoren und ihre festverdrahtete und programmierte Logik
por: Pelka, Horst
Publicado: (1977)

Digitale Elektronik: die Arbeitsweise von Logik- und Speicher-Elementen der Halbleiter-und Magnettechnik
por: Wolf, Gerhard
Publicado: (1969)

Spottdrosseln und Metalvögel: Computer-Rätsel, mathematische Abenteuer und ein Ausflug in die vogelfreie Logik
por: Smullyan, Raymond M
Publicado: (1986)

Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART‐1501 study
por: Fukuda, Minoru, et al.
Publicado: (2022)

Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management
por: Takayuki, Nakano, et al.
Publicado: (2018)

Tumor Neovascularization and Developments in Therapeutics
por: Katayama, Yuki, et al.
Publicado: (2019)

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
por: Hotta, K., et al.
Publicado: (2021)

Das irrationalitätsproblem in der ästhetik und logik des 18 jahrhunderts bis zur kritik der urteilskraft :
por: Baeumler, Alfred, 1887-1968
Publicado: (1981)

P04.08. Predictors of dietary supplement (DS) use among persons receiving home health care: findings from the 2007 national home and hospice care survey (NHHCS)
por: Bercovitz, A, et al.
Publicado: (2012)

Treatment rationale and design of the SPIRAL study: A phase II trial of osimertinib in elderly epidermal growth factor receptor T790M-positive nonsmall-cell lung cancer patients who progressed during prior EGFR-TKI treatment
por: Uchino, Junji, et al.
Publicado: (2018)

Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary Lesions
por: Imabayashi, Tatsuya, et al.
Publicado: (2019)

S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART‐1501
por: Fukuda, Minoru, et al.
Publicado: (2020)

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor–naïve patients with non–small cell lung cancer harboring EGFR mutations
por: Tanaka, Kentaro, et al.
Publicado: (2017)

Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients
por: Imabayashi, Tatsuya, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review
por: Onoi, Keisuke, et al.
Publicado: (2020)

Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review
por: Okura, Naoko, et al.
Publicado: (2020)

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)
por: Yamada, Tadaaki, et al.
Publicado: (2020)

Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab
por: Sawada, Ryo, et al.
Publicado: (2021)

Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial
por: Tanimura, Keiko, et al.
Publicado: (2023)

High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis
por: Oda, Keishi, et al.
Publicado: (2014)

Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non‐small cell lung cancer
por: Katayama, Yuki, et al.
Publicado: (2019)

Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis
por: Yoshimura, Akihiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ojghe3lnc0abjilsk5petmat5